RabLab members (Agathe Vrillon, Charles Windon, Daniel Schonhaut, David Soleimani-Meigooni, Ganna Blazhenets, Gil Rabinovici, Julien Lagarde, Maison Abu Raya, Renaud La Joie) and collaborators (Leslie Gaynor, Joseph Giorgio) will be at AAIC.
Make sure to book yourself to hear about our research:
Sat July 27
Oral presentations
3:45-4:45pm - AIC Oral Session
- Renaud La Joie - Ballroom A
Panel discussion: Neuroimaging in ADRD: Reflecting on 20 years of progress to design better studies in 2024 and beyond
Posters
8:00-5:00pm - Hall BC
- Julien Lagarde
Amyloid-PET in patients with a clinical diagnosis of sporadic early versus late-onset AD: comparison of the LEADS and ADNI cohorts
- Julien Lagarde
Characterization of the heterogeneity of amyloid-PET-negative patients with a clinical diagnosis of sporadic early-onset AD: an FDG-PET study in the LEADS cohort
- Leslie Gaynor
Medial temporal lobe subregional atrophy patterns in presymptomatic and symptomatic genetic frontotemporal lobar degeneration
- Joseph Giorgio
Data-driven analysis of 10,361 amyloid-PET scans from the IDEAS study reveals two primary axes of variation
Sun July 28
Oral presentations
8:00-8:45am - Featured Research Session
- Ganna Blazhenets - 121 ABC
Reproducibility of Centiloid Values in Real-World Amyloid PET Data: Comparison of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) to Four Large Research Datasets
8:00-8:45am - Lightning Presentation Round
- Julien Lagarde - 115 ABC
Amyloid-PET in patients with a clinical diagnosis of sporadic early versus late-onset AD: comparison of the LEADS and ADNI cohorts
Posters
8:00-4:15pm - Hall BC
- Daniel Schonhaut
A clock model of regional tau-PET accumulation and cognitive decline in sporadic early-onset Alzheimer's disease
- Agathe Vrillon
Association of 18F-flortaucipir PET with tau neuropathology in AD and other neurodegenerative disorders
- Charles Windon
Residential Neighborhood Disadvantage and Amyloid Positivity: Findings from IDEAS
Mon July 29
Oral presentations
8:00-8:45am - Developing Topics "Introduction to Amyloid PET Quantification: methodologies, utility, pearls and pitfalls" - 121 ABC
- Renaud La Joie
Introduction to PET quantification and Centiloids
- David Soleimani-Meigooni
Clinician Experience with Amyloid PET Visual Read and Centiloid Quantitation
9:00-9:10am - Perspectives Session
- Charles Windon - Nutter Theater
Learning from Real-World Data Platforms: Insights into Care and Representation in Research Through ALZ-NET and New IDEAS
2:00-3:00pm - Perspectives Session
- Renaud La Joie - Hall A
MRI biomarkers to measure LATE in vivo
2:10-2:20pm - Featured Research Session
- Gil Rabinovici - 115 ABC
Clinical Impact of Amyloid PET in Diverse Medicare Beneficiaries with Cognitive Impairment: Preliminary Results from New IDEAS
Posters
8:00-4:15pm - Posters - Hall BC
- Julien Lagarde
Characterization of the heterogeneity of amyloid-PET-negative patients with a clinical diagnosis of sporadic early-onset AD: an FDG-PET study in the LEADS cohort
Tue July 30
Posters
8:00-4:15pm - Hall BC
- Maison Abu Raya
Sex Differences in Amyloid PET in a Large, Real-Life Sample from the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Study
Wed July 31
Oral presentations
8:00-8:07am - Featured Research Session
- Leslie Gaynor - 115 ABC
Medial temporal lobe subregional atrophy patterns in presymptomatic and symptomatic genetic frontotemporal lobar degeneration
2:10-2:20pm - Featured Research Session
- Joseph Giorgio - 115 ABC
Data-driven analysis of 10,361 amyloid-PET scans from the IDEAS study reveals two primary axes of variation
